Site icon Copyleft Currents

NDAs and Chronic Care

Non-disclosure agreements (NDAs) are some of the most “plain vanilla” technology agreements around. They are usually short, and don’t vary dramatically in content from one set of boilerplate to another. Technology companies sign NDAs all the time with little or no negotiation.

In fact, despite their brevity and simplicity, NDAs are significant obligations that recipients of information should avoid. But they are also a fact of life. Think of them as a chronic disease you can’t get rid of, but have to manage.

The name of an NDA can be misleading. NDAs usually contains both non-disclosure and non-use provisions. It may be workable to avoid disclosing documents given to you, but it is harder to avoid disclosure of information given to you, whether the information was communicated in documents or oral discussions. And it is a tricky task not to use information given to you. You can’t “unlearn” information. So while the agreement is called a non-disclosure agreement, complying with the non-use requirements is the harder task. This problem is sometimes referred to as taint — being exposed to information you can’t forget but you can’t use, even if you might have come up with it independently.

To make it worse, NDAs are intrinsically expensive contracts to breach. Whereas most commercial agreement contain limitations on liability, the point of an NDA is to put the recipient on the hook for legal liability. So, violating an NDA can expose you to high damages.

Most NDAs specify a limited purpose for use of information. Most often, that purpose is to negotiate a more detailed agreement. But sometimes, the purpose is to evaluate technical or business information for a more specific purpose. Receiving technical information under NDA is more risky than receiving general business information. So while you may sign NDAs routinely to negotiate commercial deals, think carefully about your risks under NDA if you intend to evaluate a product, particularly if you will be exposed to software source code or detailed technical specifications that you may plan to independently develop. That can place you in the difficult position of “proving a negative” — that you did not use the information in breach of the NDA.

To be safe, you should talk to a lawyer before signing an NDA — but that’s easy for a lawyer to say. In the real world, legal review costs money and time. If you are presented with an NDA to sign, particularly if you are a startup, you may not have the resources to have a lawyer review the agreement. Even if you could engage a lawyer, you might not have any bargaining power to negotiate the NDA terms. That’s particularly true when you are using the NDA to negotiate your first big customer deal.

Here are some tips for managing the chronic disease that is NDAs.

You, Too, Can Learn to be a Lawyer

If you want to learn more about how to review and negotiate NDAs, you can learn to do it the same way lawyers learn. Any smart and diligent person can learn to review NDAs, and in fact, reviewing NDAs is a common task for junior lawyers as they cut their teeth on technology transactions practice. Below is a quick summary of the most common issues in NDAs. If you have the opportunity to negotiate some of these points, give it a try. But you may want to tread lightly: a fierce negation over an NDA can sour follow-on negotiations. Your potential business partner may — rightly or wrongly — consider them “standard” agreements to which no one should object. (If you want to see an example of a standardized NDA, take a look at the Waypoint NDA.)

Exit mobile version